These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2783302)

  • 1. Cytotoxicities of two disulfide-bond-linked conjugates of methotrexate with monoclonal anti-MM46 antibody.
    Umemoto N; Kato Y; Hara T
    Cancer Immunol Immunother; 1989; 28(1):9-16. PubMed ID: 2783302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
    Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
    Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of linkage and mode of action of methotrexate conjugated with antitumor antibodies: implications for future preparation of conjugates.
    Endo N; Takeda Y; Umemoto N; Kishida K; Watanabe K; Saito M; Kato Y; Hara T
    Cancer Res; 1988 Jun; 48(12):3330-5. PubMed ID: 3259466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-selective cytotoxicity of methotrexate conjugated with monoclonal anti-MM46 antibody.
    Endo N; Takeda Y; Kishida K; Kato Y; Saito M; Umemoto N; Hara T
    Cancer Immunol Immunother; 1987; 25(1):1-6. PubMed ID: 3496155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Cancer Res; 1987 Feb; 47(4):1076-80. PubMed ID: 3802092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting, internalization, and cytotoxicity of methotrexate-monoclonal anti-stage-specific embryonic antigen-1 antibody conjugates in cultured F-9 teratocarcinoma cells.
    Shen WC; Ballou B; Ryser HJ; Hakala TR
    Cancer Res; 1986 Aug; 46(8):3912-6. PubMed ID: 2873883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjugates of mitomycin C with the immunoglobulin M monomer fragment of a monoclonal anti-MM46 immunoglobulin M antibody with or without serum albumin as intermediary.
    Umemoto N; Kato Y; Takeda Y; Saito M; Hara T; Seto M; Takahashi T
    J Appl Biochem; 1984; 6(5-6):297-307. PubMed ID: 6443109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro and in vivo antitumor activity of monoclonal anti-MM46 antibody-ricin A chain conjugate].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1894-1900. PubMed ID: 6882010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of site-specific methotrexate-IgG conjugates. Comparison of stability and antitumor activity with active-ester-based conjugates.
    Kralovec J; Singh M; Mammen M; Blair AH; Ghose T
    Cancer Immunol Immunother; 1989; 29(4):293-302. PubMed ID: 2787696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and anti-tumor activity of monoclonal antibody against ascitic mammary tumor MM46 cells].
    Takahashi T; Seto M; Hara T
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):544-50. PubMed ID: 6192760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and antitumor effect of fibrinogen-methotrexate conjugate.
    Boratyński J; Opolski A; Wietrzyk J; Górski A; Radzikowski C
    Cancer Lett; 2000 Feb; 148(2):189-95. PubMed ID: 10695996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monensin is obligatory for the cytotoxic action of a disulfide linked methotrexate-anti-transferrin receptor conjugate.
    Raso V; Fehrmann C; Solan VC; Rosowsky A
    Biochem Biophys Res Commun; 1988 Jan; 150(1):104-10. PubMed ID: 3276306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor.
    Deguchi T; Chu TM; Leong SS; Horoszewicz JS; Lee CL
    Cancer Res; 1986 Aug; 46(8):3751-5. PubMed ID: 3731053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell proliferation and dihydrofolate reductase by liposomes containing methotrexate-dimyristoylphosphatidylethanolamine derivatives and by the glycerophosphorylethanolamine analogs.
    Hashimoto K; Loader JE; Knight MS; Kinsky SC
    Biochim Biophys Acta; 1985 Jun; 816(1):169-78. PubMed ID: 4005236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of methotrexate-alpha-alanine by carboxypeptidase A-monoclonal antibody conjugate.
    Haenseler E; Esswein A; Vitols KS; Montejano Y; Mueller BM; Reisfeld RA; Huennekens FM
    Biochemistry; 1992 Jan; 31(3):891-7. PubMed ID: 1731945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug/antibody conjugates. In vitro cytotoxicity of a human serum albumin-mediated conjugate of methotrexate with anti-MM46 monoclonal antibody.
    Endo N; Kato Y; Takeda Y; Saito M; Umemoto N; Kishida K; Hara T
    Acta Paediatr Jpn; 1987 Aug; 29(4):566-8. PubMed ID: 3144892
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate analogues. 21. Divergent influence of alkyl chain length on the dihydrofolate reductase affinity and cytotoxicity of methotrexate monoesters.
    Rosowsky A; Forsch RA; Yu CS; Lazarus H; Beardsley GP
    J Med Chem; 1984 May; 27(5):605-9. PubMed ID: 6585550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of radionuclides to pretargeted monoclonal antibodies using dihydrofolate reductase and methotrexate in an affinity system.
    Hawkins GA; McCabe RP; Kim CH; Subramanian R; Bredehorst R; McCullers GA; Vogel CW; Hanna MG; Pomato N
    Cancer Res; 1993 May; 53(10 Suppl):2368-73. PubMed ID: 8485723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of methotrexate-antibody conjugates by regiospecific coupling and assessment of drug and antitumor activities.
    Kralovec J; Spencer G; Blair AH; Mammen M; Singh M; Ghose T
    J Med Chem; 1989 Nov; 32(11):2426-31. PubMed ID: 2810330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-alpha-phenylalanine: optimization of methotrexate prodrug for activation by carboxypeptidase A-monoclonal antibody conjugate.
    Vitols KS; Haag-Zeino B; Baer T; Montejano YD; Huennekens FM
    Cancer Res; 1995 Feb; 55(3):478-81. PubMed ID: 7834611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.